| Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases B Xu, T Fuchs, S Dogan, I Landa, N Katabi, JA Fagin, RM Tuttle, ... Thyroid 30 (10), 1505-1517, 2020 | 213 | 2020 |
| Assessment of tumor-infiltrating lymphocytes using International TILs Working Group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma: a study of … TL Fuchs, L Sioson, A Sheen, K Jafari-Nejad, CJ Renaud, J Andrici, ... The American journal of surgical pathology 44 (4), 536-544, 2020 | 112 | 2020 |
| International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma B Xu, TL Fuchs, S Ahmadi, M Alghamdi, B Alzumaili, MA Bani, E Baudin, ... Journal of Clinical Oncology 40 (1), 96-104, 2022 | 103 | 2022 |
| Macrophage inhibitory cytokine‐1 is associated with cognitive impairment and predicts cognitive decline–the S ydney M emory and A ging S tudy T Fuchs, JN Trollor, J Crawford, DA Brown, BT Baune, K Samaras, ... Aging cell 12 (5), 882-889, 2013 | 93 | 2013 |
| NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases A Chou, T Fraser, M Ahadi, T Fuchs, L Sioson, A Clarkson, A Sheen, ... Modern Pathology 33 (5), 924-932, 2020 | 72 | 2020 |
| A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis TL Fuchs, AJ Nassour, A Glover, MS Sywak, SB Sidhu, LW Delbridge, ... The American journal of surgical pathology 44 (10), 1419-1428, 2020 | 70 | 2020 |
| Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients TL Fuchs, F Maclean, J Turchini, AC Vargas, S Bhattarai, A Agaimy, ... Modern Pathology 35 (6), 836-849, 2022 | 35 | 2022 |
| A critical assessment of postneoadjuvant therapy pancreatic cancer regression grading schemes with a proposal for a novel approach A Chou, M Ahadi, J Arena, L Sioson, A Sheen, TL Fuchs, N Pavlakis, ... The American Journal of Surgical Pathology 45 (3), 394-404, 2021 | 25 | 2021 |
| Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1) BV Janssen, S van Roessel, S van Dieren, O de Boer, V Adsay, O Basturk, ... British Journal of Surgery 110 (1), 67-75, 2023 | 21 | 2023 |
| Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study B Xu, K Viswanathan, MS Ahadi, S Ahmadi, B Alzumaili, MA Bani, ... Thyroid 34 (2), 167-176, 2024 | 20 | 2024 |
| Switch/sucrose‐non‐fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)‐deficient colorectal carcinomas are strongly associated with microsatellite instability: an … MS Ahadi, TL Fuchs, A Clarkson, A Sheen, L Sioson, A Chou, AJ Gill Histopathology 80 (6), 906-921, 2022 | 20 | 2022 |
| A clinicopathologic and molecular analysis of fumarate hydratase–deficient pheochromocytoma and paraganglioma TL Fuchs, C Luxford, A Clarkson, A Sheen, L Sioson, M Elston, ... The American journal of surgical pathology 47 (1), 25-36, 2023 | 14 | 2023 |
| A critical assessment of current grading schemes for diffuse pleural mesothelioma with a proposal for a novel mesothelioma weighted grading scheme (MWGS) TL Fuchs, A Chou, Y Aksoy, M Mahjoub, A Sheen, L Sioson, M Ahadi, ... The American Journal of Surgical Pathology 46 (6), 774-785, 2022 | 13 | 2022 |
| Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases TL Fuchs, A Pearson, J Pickett, C Diakos, R Dewar, D Chan, A Guminski, ... Pathology 52 (5), 515-521, 2020 | 10 | 2020 |
| Revisiting the significance of prominent C cells in the thyroid TL Fuchs, SE Bell, A Chou, AJ Gill Endocrine pathology 30, 113-117, 2019 | 10 | 2019 |
| Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas TL Fuchs, L Sioson, A Sheen, A Clarkson, AJ Gill Pathology 50 (4), 472-474, 2018 | 10 | 2018 |
| DNA damage‐inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of … AC Vargas, NL Chan, DD Wong, M Zaborowski, TL Fuchs, M Ahadi, ... Histopathology 79 (1), 106-116, 2021 | 9 | 2021 |
| Stromal tumour‐infiltrating lymphocytes (TILs) assessed using the ITWG system do not predict overall survival in a cohort of 337 cases of mesothelioma. TL Fuchs, A Chou, L Sioson, A Sheen, AJ Gill Histopathology 76 (7), 2020 | 9 | 2020 |
| Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram M Mahjoub, L Sioson, A Sheen, M Ahadi, A Chou, AJ Gill, TL Fuchs Pathology 54 (1), 79-86, 2022 | 8 | 2022 |
| A critical assessment of diagnostic criteria for the tall cell subtype of papillary thyroid carcinoma—how much? How tall? And when is it relevant? J Turchini, TL Fuchs, A Chou, L Sioson, A Clarkson, A Sheen, L Delbridge, ... Endocrine Pathology 34 (4), 461-470, 2023 | 7 | 2023 |
